{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:43:59Z","timestamp":1790232239019,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Croatian Ministry of Health"},{"name":"Croatian Ministry of Science and Education"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.mcn.2015.06.002","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T19:28:46Z","timestamp":1433532526000},"page":"55-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Decrease in catalytic capacity of \u03b3-secretase can facilitate pathogenesis in sporadic and Familial Alzheimer's disease"],"prefix":"10.1016","volume":"67","author":[{"given":"\u017deljko M.","family":"Svedru\u017ei\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Popovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"\u0160endula-Jengi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mcn.2015.06.002_bb0005","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-4159.2005.03578.x","article-title":"Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms","volume":"96","author":"Bentahir","year":"2006","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.mcn.2015.06.002_bb0010","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1074\/jbc.M807530200","article-title":"MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1","volume":"284","author":"Boissonneault","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"34","key":"10.1016\/j.mcn.2015.06.002_bb0015","doi-asserted-by":"crossref","first-page":"22992","DOI":"10.1074\/jbc.M804175200","article-title":"The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expression","volume":"283","author":"Burton","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"5094","key":"10.1016\/j.mcn.2015.06.002_bb0020","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1126\/science.8424174","article-title":"Release of excess amyloid beta protein from a mutant amyloid beta protein precursor","volume":"259","author":"Cai","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.mcn.2015.06.002_bb0025","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","article-title":"The mechanism of gamma-secretase dysfunction in familial Alzheimer disease","volume":"31","author":"Chavez-Gutierrez","year":"2012","journal-title":"EMBO J."},{"issue":"6405","key":"10.1016\/j.mcn.2015.06.002_bb0030","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production","volume":"360","author":"Citron","year":"1992","journal-title":"Nature"},{"issue":"7476","key":"10.1016\/j.mcn.2015.06.002_bb0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12598","article-title":"DNMT1-interacting RNAs block gene-specific DNA methylation","volume":"503","author":"Di Ruscio","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mcn.2015.06.002_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcn.2015.06.002_bb0195","article-title":"Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding (Hardcover)","author":"Fersht","year":"1998"},{"issue":"2","key":"10.1016\/j.mcn.2015.06.002_bb0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0002-9440(10)63159-8","article-title":"Beta-secretase activity increases with aging in human, monkey, and mouse brain","volume":"164","author":"Fukumoto","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.mcn.2015.06.002_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/REVNEURO.2004.15.5.353","article-title":"Mouse models of Alzheimer's disease: insight into treatment","volume":"15","author":"German","year":"2004","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.mcn.2015.06.002_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2202-9-17","article-title":"Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants","volume":"9","author":"Gorman","year":"2008","journal-title":"BMC Neurosci."},{"issue":"9","key":"10.1016\/j.mcn.2015.06.002_bb0060","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1212\/01.wnl.0000255938.33739.46","article-title":"Variations in the APP gene promoter region and risk of Alzheimer disease","volume":"68","author":"Guyant-Marechal","year":"2007","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.mcn.2015.06.002_bb0065","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer's disease correlates with increased BACE1\/beta-secretase expression","volume":"105","author":"Hebert","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.mcn.2015.06.002_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/JAD-121777","article-title":"Aftins increase amyloid-beta42, lower amyloid-beta38, and do not alter amyloid-beta40 extracellular production in vitro: toward a chemical model of Alzheimer's disease?","volume":"35","author":"Hochard","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.mcn.2015.06.002_bb0075","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ana.20144","article-title":"Increased beta-secretase activity in cerebrospinal fluid of Alzheimer's disease subjects","volume":"55","author":"Holsinger","year":"2004","journal-title":"Ann. Neurol."},{"issue":"77","key":"10.1016\/j.mcn.2015.06.002_bb0080","doi-asserted-by":"crossref","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer's disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.mcn.2015.06.002_bb0085","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.bcp.2013.12.015","article-title":"Integrating the molecular and the population approaches to dementia research to help guide the future development of appropriate therapeutics","volume":"88","author":"Hunter","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.mcn.2015.06.002_bb0090","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s12035-013-8445-3","article-title":"The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD","volume":"48","author":"Hunter","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"7409","key":"10.1016\/j.mcn.2015.06.002_bb0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer's disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.mcn.2015.06.002_bb0100","doi-asserted-by":"crossref","first-page":"14776","DOI":"10.1074\/jbc.M513453200","article-title":"Equimolar production of amyloid beta-protein and amyloid precursor protein intracellular domain from beta-carboxyl-terminal fragment by gamma-secretase","volume":"281","author":"Kakuda","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.mcn.2015.06.002_bb0105","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbagen.2009.07.016","article-title":"The unsolved relationship of brain aging and late-onset Alzheimer disease","volume":"1790","author":"Kern","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.mcn.2015.06.002_bb0110","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1074\/jbc.M505625200","article-title":"Down-regulation of endogenous amyloid precursor protein processing due to cellular aging","volume":"281","author":"Kern","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.mcn.2015.06.002_bb0115","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ajpath.2012.02.012","article-title":"Presenilin-1 L166P mutant human pluripotent stem cell-derived neurons exhibit partial loss of gamma-secretase activity in endogenous amyloid-beta generation","volume":"180","author":"Koch","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.mcn.2015.06.002_bb0120","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/humu.20336","article-title":"Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40","volume":"27","author":"Kumar-Singh","year":"2006","journal-title":"Hum. Mutat."},{"issue":"10","key":"10.1016\/j.mcn.2015.06.002_bb0125","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1073\/pnas.0205689101","article-title":"Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients","volume":"101","author":"Li","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.mcn.2015.06.002_bb0130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0006-291X(03)00797-6","article-title":"APH1, PEN2, and nicastrin increase Abeta levels and gamma-secretase activity","volume":"305","author":"Marlow","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.mcn.2015.06.002_bb0135","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1523\/JNEUROSCI.4264-11.2012","article-title":"Differential effects between gamma-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice","volume":"32","author":"Mitani","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2015.06.002_bb0140","series-title":"Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting Oxford University Press, USA","author":"Motulsky","year":"2004"},{"issue":"2","key":"10.1016\/j.mcn.2015.06.002_bb0145","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1074\/jbc.M112.419135","article-title":"Interplay between alpha-, beta-, and gamma-secretases determines biphasic amyloid-beta protein level in the presence of a gamma-secretase inhibitor","volume":"288","author":"Ortega","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mcn.2015.06.002_bb0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00401-012-1062-9","article-title":"Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease","volume":"125","author":"Pera","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"189","key":"10.1016\/j.mcn.2015.06.002_bb0155","doi-asserted-by":"crossref","first-page":"189ra77","DOI":"10.1126\/scitranslmed.3005615","article-title":"Increased in vivo amyloid-beta42 production, exchange, and loss in presenilin mutation carriers","volume":"5","author":"Potter","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.mcn.2015.06.002_bb0160","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1046\/j.1471-4159.1999.0732383.x","article-title":"Antisense-induced reduction of presenilin 1 expression selectively increases the production of amyloid beta42 in transfected cells","volume":"73","author":"Refolo","year":"1999","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.mcn.2015.06.002_bb0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.mcn.2015.06.002_bb0170","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/jnnp.2006.113514","article-title":"APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage","volume":"78","author":"Rovelet-Lecrux","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.mcn.2015.06.002_bb0175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1471-4159.2011.07213.x","article-title":"Targets for AD treatment: conflicting messages from gamma-secretase inhibitors","volume":"117","author":"Sambamurti","year":"2011","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.mcn.2015.06.002_bb0180","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cub.2006.04.004","article-title":"Modeling clinically heterogeneous presenilin mutations with transgenic Drosophila","volume":"16","author":"Seidner","year":"2006","journal-title":"Curr. Biol."},{"issue":"5927","key":"10.1016\/j.mcn.2015.06.002_bb0185","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.1171176","article-title":"Gamma-secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease","volume":"324","author":"Serneels","year":"2009","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mcn.2015.06.002_bb0190","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1073\/pnas.0608332104","article-title":"The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism","volume":"104","author":"Shen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.mcn.2015.06.002_bb0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/exnr.2002.7875","article-title":"Localization of beta-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls","volume":"175","author":"Sun","year":"2002","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.mcn.2015.06.002_bb0205","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/092986708783330700","article-title":"Mammalian cytosine DNA methyltransferase Dnmt1: enzymatic mechanism, novel mechanism-based inhibitors, and RNA-directed DNA methylation","volume":"15","author":"Svedruzic","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"45","key":"10.1016\/j.mcn.2015.06.002_bb0210","doi-asserted-by":"crossref","first-page":"14977","DOI":"10.1021\/bi050988f","article-title":"Mechanism of allosteric regulation of Dnmt1's processivity","volume":"44","author":"Svedruzic","year":"2005","journal-title":"Biochemistry"},{"issue":"27","key":"10.1016\/j.mcn.2015.06.002_bb0215","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1021\/bi050295z","article-title":"DNA cytosine C5 methyltransferase Dnmt1: catalysis-dependent release of allosteric inhibition","volume":"44","author":"Svedruzic","year":"2005","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.mcn.2015.06.002_bb0220","doi-asserted-by":"crossref","first-page":"e32293","DOI":"10.1371\/journal.pone.0032293","article-title":"Modulation of gamma-secretase activity by multiple enzyme-substrate interactions: implications in pathogenesis of Alzheimer's disease","volume":"7","author":"Svedruzic","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mcn.2015.06.002_bb0225","doi-asserted-by":"crossref","first-page":"e50759","DOI":"10.1371\/journal.pone.0050759","article-title":"Modulators of gamma-secretase activity can facilitate the toxic side-effects and pathogenesis of Alzheimer's disease","volume":"8","author":"Svedruzic","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mcn.2015.06.002_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-7-19","article-title":"Inhibition of gamma-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia","volume":"7","author":"Tamayev","year":"2012","journal-title":"Mol. Neurodegener."},{"issue":"8","key":"10.1016\/j.mcn.2015.06.002_bb0235","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/hmg\/ddg098","article-title":"Alzheimer-associated C allele of the promoter polymorphism \u221222C>T causes a critical neuron-specific decrease of presenilin 1 expression","volume":"12","author":"Theuns","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.mcn.2015.06.002_bb0240","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.clinthera.2012.01.022","article-title":"Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral gamma-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers","volume":"34","author":"Tong","year":"2012","journal-title":"Clin. Ther."},{"issue":"5","key":"10.1016\/j.mcn.2015.06.002_bb0245","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","article-title":"The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.mcn.2015.06.002_bb0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nm0103-3","article-title":"Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease","volume":"9","author":"Yang","year":"2003","journal-title":"Nat. Med."},{"issue":"32","key":"10.1016\/j.mcn.2015.06.002_bb0255","doi-asserted-by":"crossref","first-page":"23639","DOI":"10.1074\/jbc.M704601200","article-title":"{Gamma}-secretase substrate concentration modulates the Abeta42\/Abeta40 ratio: implications for Alzheimer's disease","volume":"282","author":"Yin","year":"2007","journal-title":"J. Biol. Chem."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743115000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743115000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T04:00:26Z","timestamp":1566792026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743115000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":51,"alternative-id":["S1044743115000901"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2015.06.002","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decrease in catalytic capacity of \u03b3-secretase can facilitate pathogenesis in sporadic and Familial Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2015.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}